GPNMB is a type I transmembrane glycoprotein with homology to the PMEL17 precursor, a melanocyte-specific protein. Two transcript variants encoding different isoforms exist.GPNMB is expressed in minimally (but not highly) metastatic human melanoma cell lines and xenografts and may be involved in the delay and reduction of metastatic potential and growth.
